The Trump administration's "Manhattan project" for a COVID-19 vaccine has topped its biggest award given only two weeks ago to Novavax, Inc with its latest grant of $2.1 billion to pharmaceutical giant, GlaxoSmithKline, and partner Sanofi Pasteur to "speed up clinical development and manufacturing" of its recombinant vaccine candidate for the novel
Big Pharma Giants GlaxoSmithKline, Sanofi Receive $2.1 Billion to Develop COVID Vaccine
Operation Warp Speed is handing out cash at record velocity and this time, the two largest vaccine companies in the world are benefiting.